These seven companies are among those players well-positioned to leverage the dynamics of the changing spine market.

The acquisition is intended to expand BSC’s portfolio to provide more treatment options for chronic low back pain.

Elutia announced the divestiture of the company’s orthobiologics business unit to Berkeley Biologics.

Interim appointments have been made for the positions of Chief Executive Officer, Chief Financial Officer and Chief Legal Officer.

The distribution agreement with Spartan Medical signals the rollout of RemeOs screws in the United States.

New companies are constantly entering the orthopedic market with the aim of introducing technologies that meet an unanswered clinical need.

The transaction includes the sale of all cervical and lumbar fusion products, including the STALIF technology platform.

Technologies used in spine surgery, shifting perspectives on their strategic importance and what could spur mass market adoption.

This collaboration will focus on the introduction of a novel synthetic biomaterial for bone growth, set for a 2024 launch.

Certain CD Horizon Solera spinal fixation rods made by Medtronic meet SI-BONE’s criteria for compatibility with iFuse Bedrock Granite.